Cellular, Acellular and Matrix-like Products (CAMPS) are a mainstay in the advanced therapy in the PASS.

This lecture will detail the use, billing, and reimbursement of CAMPs.

Jennie and William will delve into the intricacies of CAMP utilization and financial aspects within the post-acute setting. Additionally, Dr. Tettelbach will review evidence from big data, offering invaluable insights.